Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years or older, according to a study published online Dec. 13 in JAMA Network Open.

Medical Xpress

RSVpreF vaccine found effective in preventing severe RSV in older adults

The Federal Commission for the Protection against Health Risks (Cofepris) authorized the registration of the respiratory syncicial virus (SRV) vaccine of the pharmaceutical laboratory Pfizer, which is indicated for use in pregnant women. Protection against infection covers babies from birth to six months of age.

La Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris) autorizó el registro de la vacuna contra el virus sincicial respiratorio (VSR) del laboratorio farmacéutico Pfizer, la cual está indicada para aplicarse en embarazadas. La protección contra la infección abarca a bebés desde el nacimiento hasta los seis meses de edad.

Avala Cofepris vacuna de Pfizer contra virus sincicial respiratorio

La Jornada

Mexico

Avala Cofepris Pfizer vaccine against respiratory syncicial virus

The Federal Commission for the Protection against Health Risks (Cofepris) granted two records for the vaccine (bivalent, recombinant) against the Respiratory Syncicial Virus (RSV). The new approved vaccine is indicated for the prevention of respiratory diseases caused by SRV in infants from 0 to 6 months of age. In this case, immunization is carried out through maternal vaccination during pregnancy. It is also aimed at the prevention of acute re…

La Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris) otorgó dos registros para la vacuna (bivalente, recombinante) contra el Virus Sincicial Respiratorio (VSR). La nueva vacuna autorizada está indicada para la prevención de enfermedades respiratorias causadas por el VSR en lactantes desde los 0 hasta los seis meses de edad. En este caso, la inmunización se realiza a través de la vacunación materna durante el estado de gest…

La vacuna va dirigida a mujeres embarazadas y adultos mayores.

Once Noticias

The vaccine is targeted at pregnant women and older adults.

Archyde New RSV Vaccines Approved in mexico for Vulnerable Populations Table of Contents 1. New RSV Vaccines Approved in mexico for Vulnerable Populations 2. New RSV Vaccines Approved in Mexico, Offering Hope Against Common Respiratory Illness 3. New RSV Vaccines Offer protection Across Generations 4. Understanding RSV: Risks and Symptoms 5. Mexico Approves Two New RSV […] You can read the full story here: Cofepris Authorizes RSV Vaccines for Pr…

archyde

Cofepris Authorizes RSV Vaccines for Pregnant Women and Older Adults – Archyde

The Cofepris authorized the vaccine against the Respiratory Sincitial Virus for application to pregnant women and older adults; the aim is to avoid serious complications The Federal Commission for the Protection against Health Risks (Cofepris) authorized the vaccine against Respiratory Sincitial Virus (RSV) for application to pregnant women and older adults. For older adults, it will be applied from the age of 60, reported the Cofepris in a stat…

La Cofepris autorizó la vacuna contra el Virus Sincitial Respiratorio para su aplicación a mujeres embarazadas y adultos mayores; el objetivo es evitar complicaciones graves La Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris) autorizó la vacuna contra Virus Sincitial Respiratorio (VSR) para su aplicación a mujeres embarazadas y adultos mayores. Para adultos mayores, se aplicará a partir de los 60 años, informó la Cofepris…

Autorizan vacuna contra el Virus Sincitial Respiratorio para embarazadas y adultos mayores

CódigoQro

Respiratory Sincitial Virus Vaccine Authorized for Pregnant and Older Adults

The Federal Commission for the Protection against Health Risks (Cofepris) granted two records for the vaccine (bivalent, recombinant) against the Respiratory Syncicial Virus (RSV). This approved vaccine is indicated for the prevention of respiratory diseases caused by the SRV in infants from 0 to 6 months of age, immunization is carried out through maternal vaccination during pregnancy. The vaccine is also aimed at the prevention of acute respir…

La Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris) otorgó dos registros para la vacuna (bivalente, recombinante) contra el Virus Sincicial Respiratorio (VSR). Esta vacuna autorizada está indicada para la prevención de enfermedades respiratorias causadas por el VSR en lactantes desde los 0 hasta los seis meses de edad, la inmunización se realiza a través de la vacunación materna durante el estado de gestación. Asimismo, l…

Autoriza Cofepris vacunas contra Virus Sincicial Respiratorio (VSR) para mujeres embarazadas y adultos mayores | Capital México

Capital México

Authorizes Cofepris vaccines against Respiratory Syncicial Virus (RSV) for pregnant women and older adults  Capital Mexico

The Federal Commission for the Protection against Health Risks (Cofepris) granted two records for the vaccine (bivalent, recombinant) against the Respiratory Syncicial Virus (RSV). By official statement, the federal unit announced that the new approved vaccine is indicated for the prevention of respiratory diseases caused by the SRV in infants from 0 to 6 months of age. They detailed that immunization is carried out through maternal vaccination …

La Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris) otorgó dos registros para la vacuna (bivalente, recombinante) contra el Virus Sincicial Respiratorio (VSR). Mediante un comunicado oficial, la dependencia federal dio a conocer que la nueva vacuna autorizada está indicada para la prevención de enfermedades respiratorias causadas por el VSR en lactantes desde los 0 hasta los seis meses de edad. Detallaron que la inmunizac…

Autorizan vacunas contra Virus Sincicial para mujeres embarazadas y adultos mayores

elsiglodetorreon.com.mx

Authorize Sincicial Virus Vaccines for Pregnant Women and Older Adults

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

RSVpreF vaccine found effective in preventing severe RSV in older adults

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics